Leila Farahmand

14PUBLICATIONS
7CO-AUTHORS
Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Energy generation, conversion and storage (excl. chemical and electrical)Predictive and prognostic markersNeural engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 12, 2023
Synthesized Anti-HER2 Trastuzumab-MCC-DM1 Conjugate: An Evaluation of Efficacy and Cytotoxicity.

Soodabeh Shafiee, Roya Mirzaei, Malihe Salehi

|Jun 13, 2023
Synthesis of the scFv fragment of anti-Frizzled-7 antibody and evaluation of its effects on triple-negative breast cancer in vitro study.

Ebrahim Khodaverdi, Ali Akbar Shabani, Hamid Madanchi

|Aug 19, 2022
Anti-cancer therapeutic strategies based on HGF/MET, EpCAM, and tumor-stromal cross talk.

Khadijeh Barzaman, Rana Vafaei, Mitra Samadi

|Aug 01, 2022
Recognition of functional genetic polymorphism using ESE motif definition: a conservative evolutionary approach to CYP2D6/CYP2C19 gene variants.

Mitra Samadi, Laleh Beigi, Fatemeh Yadegari

|Mar 06, 2022
MUC1 is a potential target to overcome trastuzumab resistance in breast cancer therapy.

Aysooda Hosseinzadeh, Parnaz Merikhian, Nazanin Naseri

|Feb 06, 2022
Matrix stiffening and acquired resistance to chemotherapy: concepts and clinical significance.

Behrad Darvishi, Mohammad Reza Eisavand, Keivan Majidzadeh-A

Pageof 3

Frequent Collaborators

1 joint publications

Behrad Darvishi

1 joint publications

Mohammad Zarei

1 joint publications

Keivan Majidzadeh-A

1 joint publications

Mahdieh Shokrollahi Barough